Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IMAC HoldingsBACK Days Sales Outstanding is 0.00 as of Sep. 2025. The stock has 7 warning signs investors should review. Among 658 Healthcare Providers & Services companies, IMAC Holdings ranks worse than 99.09% on this metric.
IMAC Holdings's average Accounts Receivable for the
three
months ended in Sep. 2025 was $0.00 Mil. IMAC Holdings's Revenue for the
three
months ended in Sep. 2025 was $0.02 Mil.
Hence, IMAC Holdings's Days Sales Outstanding for the
three
months ended in Sep. 2025 was 0.00.
The historical rank and industry rank for IMAC Holdings's Days Sales Outstanding or its related term are showing as below:
BACK'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 12.06 Med: 36.98 Max: 454.93
Current: 454.93
During the past 9 years, IMAC Holdings's highest Days Sales Outstanding was 454.93. The lowest was 12.06. And the median was 36.98.
BACK's Days Sales Outstanding is ranked worse than 99.09% of 658
companies
in the Healthcare Providers & Services industry
Industry Median: 45.91
vs BACK: 454.93
IMAC Holdings's Days Sales Outstanding
declined
from Sep. 2024 (47.25) to Sep. 2025 (0.00).
Warning Sign:
If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.
IMAC Holdings (OTCPK:BACK) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
IMAC Holdings Days Sales Outstanding Related Terms
IMAC Holdings Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for IMAC Holdings's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BACK vs MSPR, HCA, THC: Days Sales Outstanding Comparison
For the Medical Care Facilities subindustry, IMAC Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IMAC Holdings Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, IMAC Holdings's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where IMAC Holdings's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IMAC Holdings (BACK) has a Days Sales Outstanding of 0.00 as of Sep. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on IMAC Holdings and its competitors. Over the past decade, IMAC Holdings' Days Sales Outstanding has ranged from 12.06 to 454.93. According to the industry distribution chart, IMAC Holdings ranks #652 out of 658 companies in the Healthcare Providers & Services industry, placing it in the top 99.1%.
Is IMAC Holdings' Days Sales Outstanding too high?
IMAC Holdings' current Days Sales Outstanding is 0.00. Over the past 10 years, this metric has ranged from a low of 12.06 to a high of 454.93. Based on the distribution chart, IMAC Holdings ranks #652 out of 658 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does IMAC Holdings' Days Sales Outstanding compare to MSPR and HCA?
According to the Healthcare Providers & Services industry distribution chart, IMAC Holdings ranks #652 out of 658 companies for Days Sales Outstanding. This places IMAC Holdings in the lower half of its industry. The industry median Days Sales Outstanding is 45.91. Historically, IMAC Holdings' own Days Sales Outstanding has ranged from 12.06 to 454.93 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.91, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on IMAC Holdings and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IMAC Holdings's current Days Sales Outstanding is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMAC Holdings stock overvalued right now?
IMAC Holdings (BACK) has a current Days Sales Outstanding of 0.00. The current Days Sales Outstanding is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For IMAC Holdings (BACK), the current Days Sales Outstanding is 0.00 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
IMAC Holdings Inc is engaged in providing services related to proteomic products that identify and support oncology clinical treatment decisions and biopharmaceutical drug development. The Company has determined that it currently operates in a single segment, precision medicine in cancer treatment, located in a single geographic location, the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BACK has been successfully added to your 
